• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

ALung Technologies Inc.

ALung Technologies raises $2m

June 2, 2020 By Sean Whooley

ALung Technologies filed an SEC Form D to confirm the sale of $2 million in debt, options, warrants and other rights to purchase securities. The Pittsburgh-based company made its first sale in the new notice on May 20 and reached its offering total of $2 million by June 1. Just one investor participated in the […]

Filed Under: Business/Financial News, Funding Roundup, Respiratory Tagged With: ALung Technologies Inc.

FDA grants ALung EUA for respiratory assist system

April 24, 2020 By Sean Whooley

ALung Technologies announced today that it received FDA emergency use authorization (EUA) for its Hemolung respiratory assist system (RAS) for treating COVID-19. Pittsburgh-based ALung said in a news release that it already treated numerous COVID-19 patients in the U.S. under existing FDA emergency use provisions, as well as in Europe, where it’s had CE Mark […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: ALung Technologies Inc., coronavirus, COVID-19, FDA

Safety board OK’s continuing trial of ALung’s Hemolung RAS device

May 9, 2019 By Fink Densford

ALung Technologies said yesterday that it won approval from an independent Data and Safety Monitoring board to continue the U.S.-based VENT-AVOID clinical trial of its low-flow extracorporeal carbon dioxide removal technology intended to treat COPD patients with acute respiratory failure. The Pittsburgh-based company said that the VENT-AVOID trial looks to validate the safety and efficacy […]

Filed Under: Clinical Trials, Respiratory Tagged With: ALung Technologies Inc.

Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup

January 10, 2019 By Fink Densford

Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. The Lowell, Mass.-based medtech company is developing the Tetranite injectable, synthetic adhesive solution intended for bone repair. Tetranite is bioresorbable and is designed to provide instant adhesive capabilities to treat fractured bone and to stabilize metal […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: ALung Technologies Inc., babyscripts, BioCardia, conextionsmedical, Conventus Orthopaedics, cynerio, decisionsciencesmedical, Jarvik Heart, launchpadmedical, Leviticus Cardio, Philips, seraphbiosciences

ALung submits FDA IDE app for HemoLung device

April 25, 2017 By Fink Densford

ALung Technologies said today it submitted an investigational device exemption application to the FDA as it seeks to begin a clinical study of its Hemolung Respiratory Assist System. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood […]

Filed Under: Food & Drug Administration (FDA), Respiratory Tagged With: ALung Technologies Inc.

ALung closes $36m Series C

April 11, 2017 By Fink Densford

Artificial lung-like device developer ALung Technologies said today it closed a $36 million Series C financing round, with funds slated to support a US pivotal trial of its Hemolung respiratory assist system as it pursues FDA approval. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon […]

Filed Under: Business/Financial News, Respiratory Tagged With: Abiomed, ALung Technologies Inc., Philips

ALung raises $2.6m

February 17, 2017 By Fink Densford

Artificial lung-like device developer ALung Technologies raised $2.6 million in a new round of debt and options financing, according to an SEC filing posted this week. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via […]

Filed Under: Business/Financial News, Respiratory Tagged With: ALung Technologies Inc.

ALung Technologies brings in $2.6m

January 10, 2017 By Fink Densford

  Artificial lung-like device developer ALung Technologies has raised $2.6 million in a new round of financing, according to an SEC filing posted this week. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted […]

Filed Under: Business/Financial News, Respiratory Tagged With: ALung Technologies Inc.

Artificial lung developer ALung raises $12m

February 22, 2016 By Fink Densford

Artificial lung-like device developer ALung Technologies said today it closed a $12 million round of financing to support the continued commercialization of its minimally invasive Hemolung Respiratory Assist System. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small […]

Filed Under: Business/Financial News, Respiratory Tagged With: ALung Technologies Inc.

ALung’s artificial lung tech selected for landmark pivotal trial

December 2, 2015 By Fink Densford

ALung Technologies said today its Hemolung RAS extracorporeal carbon dioxide removal device has been selected for use in the world’s 1st pivotal trial of ECCO2R technology used to treat patients with acute respiratory failure. The U.K.’s National Institute for Health Research will supply $3.1 million (GBP £2.1 million) in funding for the 1,120 patient Rest […]

Filed Under: Clinical Trials, Respiratory Tagged With: ALung Technologies Inc.

Senseonics gains funding for continuous glucose monitoring implant | Medtech funding for the week of June 2, 2014

June 6, 2014 By MassDevice Leave a Comment

Diabetes: Senseonics raises $20M for continuous glucose monitoring implant

June 5, 2014 by Arezu Sarvestani

Filed Under: Funding Roundup, News Well Tagged With: ALung Technologies Inc., depuysynthes, Johnson and Johnson, Premia Spine Ltd., Senseonics, Spinal Kinetics, Transcatheter Technologies GmbH

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS